Clinical Trial Update: Sirolimus for Autoimmune Disease of Blood Cells [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating sirolimus for autoimmune blood cell disorders, including autoimmune pancytopenia and ALPS; the study is completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Hemolytic Autoimmune
• Autoimmune Lymphoproliferative Syndrome
• Autoimmune Neutropenia
• Autoimmune Pancytopenia
• Evans Syndrome
• Idiopathic Thrombocytopenic Purpura
• Lupus Erythematosus Systemic
• Rheumatoid Arthritis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Autoimmune Pancytopenia, Autoimmune Lymphoproliferative Syndrome (ALPS) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-12-06